https://www.selleckchem.com/pr....oducts/i-bet151-gsk1
This review aims to provide an introduction to the applications of magnetic nanoparticles in RA, focusing on the latest advances, challenges, and opportunities for future development. To determine the clinical utility of blood tests as a screening tool for metabolic abnormalities in patients with kidney stone disease. Clinical and biochemical data from 709 patients attending the Oxford University Hospitals NHS Foundation Trust for assessment and treatment of kidney stones were prospectively collected between April 2011 and
Curtir
Comentario
Compartilhar
